Publication | Closed Access

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

Surgical OncologyOncologyMelanomaImmunologyClinical TrialsInterferon Alfa 2BStage Iib/iii MelanomaPost-surgery Adjuvant TherapyCancer TreatmentMedicine